{"id":"https://openalex.org/W2076358425","doi":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","title":"Review of yellow cards (1986): report to the Committee on the Safety of Medicines.","display_name":"Review of yellow cards (1986): report to the Committee on the Safety of Medicines.","publication_year":1988,"publication_date":"1988-12-01","ids":{"openalex":"https://openalex.org/W2076358425","doi":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","mag":"2076358425","pmid":"https://pubmed.ncbi.nlm.nih.gov/3242573","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1386581"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.1988.tb05305.x","doi":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1988.tb05305.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1988.tb05305.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113709937","display_name":"J L","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JL Bem","raw_affiliation_strings":["Committee on the Safety of Medicines, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee on the Safety of Medicines, London","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110325039","display_name":"AM Breckenridge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AM Breckenridge","raw_affiliation_strings":["Committee on the Safety of Medicines, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee on the Safety of Medicines, London","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110139795","display_name":"RD Mann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RD Mann","raw_affiliation_strings":["Committee on the Safety of Medicines, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee on the Safety of Medicines, London","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113636634","display_name":"MD Rawlins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MD Rawlins","raw_affiliation_strings":["Committee on the Safety of Medicines, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee on the Safety of Medicines, London","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":4.1714,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.93336418,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"26","issue":"6","first_page":"679","last_page":"689"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/yellow-card-scheme","display_name":"Yellow Card Scheme","score":0.7590000033378601},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9210000038146973},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.597000002861023},{"id":"https://openalex.org/keywords/serious-adverse-drug-reactions","display_name":"serious adverse drug reactions","score":0.6890000104904175},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.6959999799728394},{"id":"https://openalex.org/keywords/cutaneous-adverse-effects","display_name":"cutaneous adverse events","score":0.8629999756813049},{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":0.9430000185966492},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9869999885559082},{"id":"https://openalex.org/keywords/enalapril","display_name":"enalapril","score":1.0},{"id":"https://openalex.org/keywords/etodolac","display_name":"etodolac","score":0.996999979019165},{"id":"https://openalex.org/keywords/british-national-formulary","display_name":"British National Formulary","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7903690338134766},{"id":"https://openalex.org/C100406419","wikidata":"https://www.wikidata.org/wiki/Q3543802","display_name":"Formulary","level":2,"score":0.7536499500274658},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6026988625526428},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45875856280326843},{"id":"https://openalex.org/C2775940317","wikidata":"https://www.wikidata.org/wiki/Q422185","display_name":"Enalapril","level":4,"score":0.4140776991844177},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3062204122543335},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19294726848602295},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.06300577521324158},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.1988.tb05305.x","doi":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1988.tb05305.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1386581","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1386581","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:3242573","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3242573","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.1988.tb05305.x","doi":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1988.tb05305.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1988.tb05305.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2076358425.pdf","grobid_xml":"https://content.openalex.org/works/W2076358425.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W1993888409","https://openalex.org/W2022714644","https://openalex.org/W2027708325","https://openalex.org/W4213219551","https://openalex.org/W4244637108"],"related_works":["https://openalex.org/W1979686287","https://openalex.org/W4231847675","https://openalex.org/W2067002985","https://openalex.org/W2953029543","https://openalex.org/W1977831629","https://openalex.org/W2060450925","https://openalex.org/W2055336343","https://openalex.org/W2982215380","https://openalex.org/W2027708325","https://openalex.org/W2974738057"],"abstract_inverted_index":{"1.":[0],"In":[1],"1986":[2,108],"the":[3,11,20,27,32,37,43,68,80,85,89,96,102,121],"CSM":[4],"received":[5,14,117],"15,527":[6],"yellow":[7,38],"cards.":[8],"This":[9],"was":[10,29,62],"highest":[12],"number":[13],"in":[15,23,42,60,118],"any":[16],"one":[17],"year":[18],"since":[19],"scheme":[21],"started":[22],"1964.":[24],"Much":[25],"of":[26,36,55,57,67,111,113,123],"increase":[28],"due":[30],"to":[31,65],"use":[33,122],"by":[34],"doctors":[35],"cards":[39],"now":[40],"included":[41],"British":[44],"National":[45],"Formulary":[46],"and":[47,95,107,133],"NHS":[48],"prescription":[49],"pads.":[50],"2.":[51],"The":[52,71],"overall":[53],"profile":[54],"reports":[56,112],"serious":[58,75,114],"reaction,":[59],"1986,":[61],"broadly":[63],"similar":[64],"that":[66],"previous":[69],"years.":[70],"most":[72],"commonly":[73],"reported":[74],"suspected":[76],"adverse":[77],"reactions":[78,115],"involved":[79],"gastro-intestinal":[81],"tract":[82],"(801":[83],"reports),":[84,88,94,126,129],"skin":[86],"(539":[87],"central":[90],"nervous":[91],"system":[92],"(535":[93],"blood":[97],"(505":[98],"reports).":[99,136],"3.":[100],"Of":[101],"drugs":[103],"introduced":[104],"between":[105],"1984":[106],"appreciable":[109],"numbers":[110],"were":[116],"association":[119],"with":[120],"diltiazem":[124],"(33":[125],"mitozantrone":[127],"(30":[128],"enalapril":[130],"(173":[131],"reports)":[132],"etodolac":[134],"(27":[135]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}